Cargando…

Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma

OBJECTIVES: To investigate the distribution of serum calcium and the relationship between serum calcium and serum metabolic parameters in endometrial carcinoma (EC) patients. METHODS: Retrospective assessment of patients diagnosed with endometrial cancer from Peking University People's Hospital...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yanying, Zhou, Jingyi, Cao, Linlin, Xu, Qi, Hao, Juan, Zhao, Lijun, Wang, Jianliu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304409/ https://www.ncbi.nlm.nih.gov/pubmed/30479096 http://dx.doi.org/10.3802/jgo.2019.30.e12

Ejemplares similares

Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress
por: Zhou, Jingyi, et al.
Publicado: (2022)

Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention
por: Huang, Ting, et al.
Publicado: (2022)

An elevated preoperative serum calcium level is a significant predictor for positive peritoneal cytology in endometrial carcinoma
por: Li, Xingchen, et al.
Publicado: (2019)

Estrogen-Induced Extracellular Calcium Influx Promotes Endometrial Cancer Progress by Regulating Lysosomal Activity and Mitochondrial ROS
por: Shen, Boqiang, et al.
Publicado: (2022)

Calcium-Related Genes Predicting Outcomes and Serving as Therapeutic Targets in Endometrial Cancer
por: Huang, Ting, et al.
Publicado: (2022)

The Role of Metabolic Syndrome in Endometrial Cancer: A Review
por: Yang, Xiao, et al.
Publicado: (2019)

Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2021)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1
por: Yang, Yuan, et al.
Publicado: (2017)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
por: Yang, Xiao, et al.
Publicado: (2021)

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016)

Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer
por: Li, Xingchen, et al.
Publicado: (2020)

Development and Validation of a Nomogram Based on Metabolic Risk Score for Assessing Lymphovascular Space Invasion in Patients with Endometrial Cancer
por: Wang, Jingyuan, et al.
Publicado: (2022)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients
por: Fan, Yuan, et al.
Publicado: (2021)

A detailed analysis of lymph node recurrence in endometrial carcinoma
por: Li, He, et al.
Publicado: (2022)

Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest
por: Yin, Fufen, et al.
Publicado: (2019)

Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer
por: Zhai, Lirong, et al.
Publicado: (2023)

Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer
por: Liu, Jie, et al.
Publicado: (2023)

Relationship between Hypothyroidism and Endometrial Cancer
por: Wang, Yiqin, et al.
Publicado: (2019)

Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2020)

The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
por: Wang, Yiqin, et al.
Publicado: (2021)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes
por: Yang, Xiao, et al.
Publicado: (2022)

The Regulatory Roles of Mitochondrial Calcium and the Mitochondrial Calcium Uniporter in Tumor Cells
por: Zhang, Linlin, et al.
Publicado: (2022)

Bone Metastases of Endometrial Carcinoma Treated by Surgery: A Report on 13 Patients and a Review of the Medical Literature
por: Wang, Jingyuan, et al.
Publicado: (2022)

Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
por: Li, Xingchen, et al.
Publicado: (2023)

Additional Value of PET/CT-Based Radiomics to Metabolic Parameters in Diagnosing Lynch Syndrome and Predicting PD1 Expression in Endometrial Carcinoma
por: Wang, Xinghao, et al.
Publicado: (2021)

Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review
por: Zhai, Lirong, et al.
Publicado: (2021)

Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
por: Zhang, Xiaobo, et al.
Publicado: (2022)

The Role of Serum Calcium Levels in Pediatric Dyslipidemia: Are There Any?
por: Peng, Yaguang, et al.
Publicado: (2021)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
por: Fan, Yuan, et al.
Publicado: (2021)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

Altered protein expression in serum from endometrial hyperplasia and carcinoma patients
por: Wang, Yi-sheng, et al.
Publicado: (2011)

Increased Serum Calcium Level Promotes the Risk of Lymph Node Metastasis in Endometrial Cancer
por: Li, Xing-Chen, et al.
Publicado: (2020)

Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples
por: Cuesta-Guardiola, Tatiana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9l5bu1ibpph1uk90higc48cc2c